Gaurav Maini
Stock Analyst at LifeSci Capital
(3.83)
# 1,934
Out of 4,600 analysts
36
Total ratings
68.4%
Success rate
21.3%
Average return
Main Sectors:
Stocks Rated by Gaurav Maini
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TENX Tenax Therapeutics | Maintained: Buy | $35 | $13.86 | +152.53% | 8 | Aug 3, 2026 | |
| CTNM Contineum Therapeutics | Maintained: Buy | $24 | $15.64 | +53.45% | 1 | Jul 31, 2026 | |
| CNTM ConnectM Technology Solutions, Inc. | Initiated Coverage: Buy | $24 | $5.49 | +337.16% | 1 | Jul 30, 2026 | |
| LQDA Liquidia | Maintained: Buy | $101 | $88.85 | +13.67% | 5 | Jul 25, 2026 | |
| SION Sionna Therapeutics | Maintained: Buy | $60 | $51.14 | +17.32% | 10 | Jun 22, 2026 | |
| TECX Tectonic Therapeutic | Rated: Buy | $88 | $29.20 | +201.37% | 7 | Jun 10, 2026 | |
| IKT Inhibikase Therapeutics | Maintained: Buy | $5 | $2.29 | +118.82% | 4 | May 16, 2026 |
Tenax Therapeutics
Aug 3, 2026
Maintained: Buy
Price Target: $35
Current: $13.86
Upside: +152.53%
Contineum Therapeutics
Jul 31, 2026
Maintained: Buy
Price Target: $24
Current: $15.64
Upside: +53.45%
ConnectM Technology Solutions, Inc.
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $5.49
Upside: +337.16%
Liquidia
Jul 25, 2026
Maintained: Buy
Price Target: $101
Current: $88.85
Upside: +13.67%
Sionna Therapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $60
Current: $51.14
Upside: +17.32%
Tectonic Therapeutic
Jun 10, 2026
Rated: Buy
Price Target: $88
Current: $29.20
Upside: +201.37%
Inhibikase Therapeutics
May 16, 2026
Maintained: Buy
Price Target: $5
Current: $2.29
Upside: +118.82%